FxWirePro- Major Pair levels and bias summary
Oct 28, 2024 16:41 pm UTC| Technicals
Major Pair levels and bias...
Oct 28, 2024 16:11 pm UTC| Technicals
SP 500- 5829 (0.42%) Major resistance- 6000 Near-term resistance - 5900, 5951 (161.8% Fib) Minor support- 5780/5750/5678 Trend reversal level- 5480 The pair holds above short-term (34, 55 EMA)...
FxWirePro: GBP/USD edges higher but outlook still bearish
Oct 28, 2024 15:50 pm UTC| Technicals
GBP/USD gained some updise momentun on Monday but gains were limited as the market awaited the upcoming release of the UK budget on Oct. 30. GBP/USD bulls are facing a critical test with the release of UK Finance...
FxWirePro- BNBUSD Daily Outlook
Oct 28, 2024 15:43 pm UTC| Digital Currency Technicals
Intraday Outlook - Neutral Key Level to Monitor:$550 A closing price above $615would suggest that the upward trend is likely to persist. The BNB/USD pairshowed a minor pullback after hitting a low of $565. Current...
Oct 28, 2024 12:23 pm UTC| Technicals
EURGBP trades weak due to policy divergence between the ECB and BOE. Intraday bias remains bearish as long as resistance 0.8380 holds. It hit a high of 0.83427 at the time of writing and is currently trading around...
Oct 28, 2024 12:14 pm UTC| Technicals
Intraday bias remains bullish as long as support 0.8550 holds. It hit a high of 0.86696 and is currently trading around 0.86589. The policy divergence between the US Fed and SNB supports the pair at lower...
FxWirePro- Major European Indices
Oct 28, 2024 10:22 am UTC| Technicals
Germany DAX - 19560 (0.49% ) Major resistance- 20000 Near-term resistance - 19680,19825 Minor support- 19400,19302,19200,19000,18845(200- 4H EMA) Trend reversal level- 17000 The pair hold...
FxWirePro- Major Economic events for th day
FxWirePro-Major Economic events for the week
China's Services Sector Soars: December PMI Hits Highest Level Since June
Galaxy Z Flip FE and Watch8 Classic Rumored in Database Leak as Samsung Plans August Unpacked Reveal
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update